The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy
Authors:
- Masaki KaiboriMasaki Kaibori
- Kengo YoshiiKYKengo Yoshii
- Kosuke MatsuiKMKosuke Matsui
- Hideyuki MatsushimaHMHideyuki Matsushima
- Hisashi KosakaHKHisashi Kosaka
- Hidekazu YamamotoHYHidekazu Yamamoto
- Takayoshi NakajimaTNTakayoshi Nakajima
- Kazunori AoiKAKazunori Aoi
- Takashi YamaguchiTYTakashi Yamaguchi
- Katsunori YoshidaKYKatsunori Yoshida
- Mitsugu SekimotoMSMitsugu Sekimoto
Open Access
Abstract
Background/Purpose: The effect of the ABO blood group on the survival of patients with hepatocellular carcinoma (HCC) is unclear. The aim of the present study is to determine the prognostic impact of ABO blood types on the survival of a Japanese population of patients with HCC who underwent surgical resection. Methods: Patients with HCC (n = 480) who underwent an R0 resection between 2010 and 2020 were retrospectively analyzed. Survival outcomes were investigated according to ABO blood type (A, B, O, or AB). Outcomes for type A (n = 173) and non-type A (n = 173) groups after surgery were compared using 1-to-1 propensity score matching to control for variables. Results: In the study cohort, 173 (36.0%), 133 (27.7%), 131 (27.3%), and 43 (9.0%) of participants had Type A, O, B, and AB, respectively. Type A and non-type A patients were successfully matched based on liver function and tumor characteristics. Recurrence-free survival (RFS; hazard ratio [HR] 0.75, 95% confidence interval [Cl] 0.58–0.98, p = 0.038) and overall survival (OS; HR: 0.67, 95% Cl: 0.48–0.95, p = 0.023) for patients with blood type A were both significantly decreased relative to non-type A patients. Cox proportional hazard analysis demonstrated that patients with HCC who have blood type A had a worse prognosis than those with non-type A blood. Conclusion: ABO blood type may have a prognostic impact on patients with HCC after hepatectomy. Blood type A is an independent unfavorable prognostic factor for recurrence-free and overall survival (RFS and OS) after hepatectomy.Keywords
This publication has 43 references indexed in Scilit:
- ABO blood group: old dogma, new perspectivesClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomyJournal of Hepatology, 2012
- ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case-Control Study in Patients with Chronic Hepatitis BPLOS ONE, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- ABO blood group and incidence of epithelial ovarian cancerInternational Journal of Cancer, 2010
- ABO Blood Group and Incidence of Skin CancerPLOS ONE, 2010
- ABO Blood Group and the Risk of Pancreatic CancerJNCI: Journal of the National Cancer Institute, 2009
- Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 WomenPLOS Genetics, 2008
- A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)PLOS Genetics, 2008
- Classification of Surgical ComplicationsAnnals of Surgery, 2004